A pilot dose finding study of pioglitazone in autistic children

A pilot dose finding study of pioglitazone in autistic children

Abstract Background Pioglitazone is a promising compound for treatment of core autism spectrum disorder (ASD) symptoms as it targets multiple relevant pathways, including immune system alterations. Objective This pilot study aimed to elucidate the maximum tolerated dose, safety, preliminary evidence...

Full description

Bibliographic Details
Main Authors: Lucia Capano, Annie Dupuis, Jessica Brian, Deepali Mankad, Lisa Genore, Rianne Hastie Adams, Sharon Smile, Toni Lui, Dina Odrobina, Jane A. Foster, Evdokia Anagnostou
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Molecular Autism
Subjects:
Pioglitazone
Autism spectrum disorder
Cytokines
Treatment
Clinical trial
Efficacy
Online Access:http://link.springer.com/article/10.1186/s13229-018-0241-5

Internet

http://link.springer.com/article/10.1186/s13229-018-0241-5

Similar Items